Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination

Journal of Infectious Diseases

Volumn 211, Issue 6, 2015, Pages 898-905

  Lambert, Nathaniel D ^a   Haralambieva, Iana H ^a   Kennedy, Richard B ^a   Ovsyannikova, Inna G ^a   Pankratz, Vernon Shane ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

genetic; genome wide association study; humoral; immunity; measles mumps rubella vaccine; neutralizing antibody; polymorphism

Indexed keywords

HLA DPB1 ANTIGEN; MEASLES MUMPS RUBELLA VACCINE; NEUTRALIZING ANTIBODY; RUBELLA ANTIBODY; 3' UNTRANSLATED REGION; HLA DP ANTIGEN; HLA-DPB1 ANTIGEN; RUBELLA VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHILD; FEMALE; GENETIC ASSOCIATION; HLA DPB1 GENE; HUMAN; HUMORAL IMMUNITY; MALE; PRIORITY JOURNAL; RUBELLA; SINGLE NUCLEOTIDE POLYMORPHISM; 3' UNTRANSLATED REGION; BLOOD; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; RUBELLA VIRUS; VACCINATION; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HLA-DP BETA-CHAINS; HUMANS; IMMUNITY, HUMORAL; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; VACCINATION; YOUNG ADULT;

EID: 84924351864     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu553     Document Type: Article

References (43)

1. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2:781-4
2. Plotkin SA, Reef SE, Cooper LZ, Alford CA Jr. Rubella. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, eds. Infectious diseases of the fetus and newborn infant. 7th ed. Philadelphia: Elsevier, 2011:861-98
3. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14:306-15
4. Paradowska-Stankiewicz I, Czarkowski MP, Derrough T, Stefanoff P. Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections. Euro Surveill 2013; 18: pii:20485
5. Janta D, Stanescu A, Lupulescu E, Molnar G, Pistol A. Ongoing rubella outbreak among adolescents in Salaj, Romania, September 2011- January 2012. Euro Surveill 2012; 17: pii:20089
6. Minakami H, Kubo T, Unno N. Causes of a nationwide rubella outbreak in Japan, 2012-2013. J Infect 2014; 68:99-101
7. Freestone DS, Reynolds GM, McKinnon JA, Prydie J. Vaccination of schoolgirls against rubella.Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley. Brit J Prev Soc Med 1975; 29:258-61
8. Bottiger M, Heller L. Experiences from vaccination and revaccination of teenage girls with three different rubella vaccines. J Biol Stand 1976; 4:107-14
9. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008; 197:950-6
10. LeBaron CW, Forghani B, Matter L, et al. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 2009; 200:888-99
11. Lambert ND, Pankratz VS, Larrabee BR, et al. High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers. Clin Vaccine Immunol 2014; 21:340-6
12. Greenwood NP, Ovsyannikova IG, Vierkant RA, O'Byrne MM, Poland GA. A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays. Viral Immunol 2010; 23:353-7
13. Lambert ND, Haralambieva IH, Ovsyannikova IG, Larrabee BR, Pankratz VS, Poland GA. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts. Immunol Res 2013; 58:1-8
14. Jacobson RM, Ovsyannikova IG, Poland GA. Genetic basis for variation of vaccine response: our studies with rubella vaccine. Paediatr Child Health 2009; (supp 2):S156-9
15. Ovsyannikova IG, Jacobson RM, Vierkant RA, O'Byrne MM, Poland GA. Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 2009; 27:6926-31
16. Dhiman N, Haralambieva IH, Kennedy RB, et al. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 2010; 62:197-210
17. Ovsyannikova IG, Haralambieva IH, Dhiman N, et al. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 2010; 201:207-13
18. Haralambieva IH, Dhiman N, Ovsyannikova IG, et al. 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 2010; 71:383-91
19. Kennedy RB, Ovsyannikova IG, Vierkant RA, Jacobson RM, Poland GA. Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses. Hum Immunol 2010; 71:128-35
20. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004; 65:1506-15
21. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella- II vaccination. J Infect Dis 2005; 191:515-9
22. Ovsyannikova IG, Dhiman N, Haralambieva IH, et al. Rubella vaccineinduced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010; 127:207-21
23. Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. The association of CD46, SLAM, and CD209 cellular receptor gene SNPs with variations in measles vaccine- induced immune responses-a replication study and examination of novel polymorphisms. Hum Hered 2011; 72:206-23
24. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine 2012; 30:2146-52
25. Cleveland WS, Gross E, Shyu WM. Local regression models. In: Chambers JM, Hastie TJ, eds. Statistical models: Wadsworth & Brooks/Cole, 1992
26. Kennedy RB, Ovsyannikova IG, Pankratz VS, et al. Genome-wide genetic associations with IFNgamma response to smallpox vaccine. Hum Genet 2012; 131:1433-51
27. Kennedy RB, Ovsyannikova IG, Shane PV, Haralambieva IH, Vierkant RA, Poland GA. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet 2012; 131:1403-21
28. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine 2012; 30:4182-9
29. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006; 38:904-9
30. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55:997-1004
31. Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26:2336-7
32. Panagiotou OA, Ioannidis JP. What should the genome-wide significance threshold be?. Empirical replication of borderline genetic associations. Int J Epidemiol 2012; 41:273-86
33. Bhattacharya A, Ziebarth JD, Cui Y. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 2014; 42:D86-91
34. Haralambieva IH, Oberg AL, Ovsyannikova IG, et al. Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One 2013; 8:e62149
35. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-5
36. Thomas R, Thio CL, Apps R, et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 2012; 86:6979-85
37. Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Gen 2011; 20:3884-92
38. Urabe Y, Ochi H, Kato N, et al. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region. J Hepatol 2013; 58:875-82
39. Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Gen 2011; 20:3893-8
40. Jacobson RM, Ovsyannikova IG, Vierkant RA, Shane PV, Poland GA. Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: Persistence, dampening, and extinction of associations found after a first dose. Vaccine 2011; 29:7982-91
41. Stephens HA, Brown AE, Chandanayingyong D, et al. The presence of the HLA class II allele DPB1. ∗0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen. Eur J Immunol 1995; 25:3142-7
42. Zhou Y, Ushijima H, Frey TK. Genomic analysis of diverse rubella virus genotypes. J Gen Virol 2007; 88:932-41
43. Best JM, Thomson A, Nores JR, O'Shea S, Banatvala JE. Rubella virus strains show nomajor antigenic differences. Intervirology 1992; 34:164-8